C. Stephen Foster

Active 1978–2024

Also published as
C.Stephen Foster
183
Papers
25,912
Citations
101
h-index
181
i10-index

Citations

Citations per year for C. Stephen Foster1979: 2 citations1980: 5 citations1981: 6 citations1982: 7 citations1983: 8 citations1984: 8 citations1985: 7 citations1986: 12 citations1987: 10 citations1988: 17 citations1989: 13 citations1990: 22 citations1991: 34 citations1992: 23 citations1993: 35 citations1994: 37 citations1995: 45 citations1996: 27 citations1997: 58 citations1998: 74 citations1999: 84 citations2000: 111 citations2001: 67 citations2002: 101 citations2003: 115 citations2004: 129 citations2005: 167 citations2006: 127 citations2007: 155 citations2008: 107 citations2009: 149 citations2010: 136 citations2011: 185 citations2012: 164 citations2013: 179 citations2014: 156 citations2015: 135 citations2016: 139 citations2017: 131 citations2018: 114 citations2019: 478 citations2020: 430 citations2021: 481 citations2022: 357 citations2023: 221 citations2024: 346 citations2025: 136 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,648 citing papers, 28.6% of this breakdownUnited Kingdom: 496 citing papers, 8.6% of this breakdownChina: 344 citing papers, 6% of this breakdownGermany: 283 citing papers, 4.9% of this breakdownItaly: 268 citing papers, 4.6% of this breakdownFrance: 210 citing papers, 3.6% of this breakdownIndia: 203 citing papers, 3.5% of this breakdownJapan: 196 citing papers, 3.4% of this breakdownAustralia: 188 citing papers, 3.3% of this breakdownSpain: 160 citing papers, 2.8% of this breakdownCanada: 158 citing papers, 2.7% of this breakdownNetherlands: 143 citing papers, 2.5% of this breakdown
0%28.6%Other 25.5%

Fields

  • Medicine85%
  • Immunology and Microbiology7.3%
  • Biochemistry, Genetics and Molecular Biology3.9%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Neuroscience0.9%
  • Social Sciences0.6%
  • Other1.3%

Topics

  • Ocular Diseases and Behçet’s Syndrome10.3%
  • Ocular Surface and Contact Lens6.3%
  • Corneal Surgery and Treatments5.9%
  • Corneal surgery and disorders4%
  • Ocular Infections and Treatments3.3%
  • Retinal Diseases and Treatments2.8%
  • Other67.4%

Coauthors

All papers

Open in search
  1. Long-term side effects of glucocorticoids

    Authors: , , , , - Expert Opinion on Drug Safety 2016 cited by 840

  2. Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy

    Authors: , , , , , , , , , , , , , - Ophthalmology 2019 cited by 275

  3. Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lajos Szalczer, Balázs Varsányi, Eytan Z. Blumenthal, Orna Geyer, Shmuel Lavartovsky, Tamar Pedut-Kloizman, Nir Shoham-Hazon, Silvio Lujan, Benjamin Abela, Robert Edward T. Ang, Edgar U. Leuenberger, Harvey S. Uy, Maria Imelda R. Yap-Veloso, Piotr Fryczkowski, Piotr Jurowski, Bartłomiej J. Kałużny, Józef Kalużny, Marta Misiuk‐Hojło, Krystyna Raczyńska, Wioletta Tomczyk-Dorozynska, J Wasyluk, S Zalewski, Tomasz Żarnowski, Julian Garcia Feijoó, R. Giménez-Gómez, Elena Millà Griñó, Alfonso Antón López, Merce Guarro Miralles, Javier Montero Moreno, Vicente Polo, Enrique Cervera Taulet, Beatriz Ponte, Yingying Chen, Yuan‐Chieh Lee, Louis Alpern, Michael S. Berlin, Jacob W. Brubaker, Delmar R. Caldwell, Andrew Camp, Louis B. Cantor, Ronald M. Caronia, Charles J. Crane, Douglas G. Day, Eran Duzman, John L Elfervig, Shérif M. El-Harazi, Richard Evans, Ann C. Fisher, William J. Flynn, C. Stephen Foster, R. E. P. Frenkel, Raj Goyal, Ronald L. Gross, Paul J. Hartman, William L. Haynes, Gary Jerkins, Janet Kim, Max Kim, Bradley Kwapiszeski, Benjamin Lambright, Christine L. Larsen, James D. Lehmann, Jeffrey Levenson, Dwayne K. Logan, Brian McMillan, Joseph R. Martel, Hylton R. Mayer, Felipe A. Medeiros, Sayoko E. Moroi, Andrew L. Moyes and 27 more - Ophthalmology 2020 cited by 125

  4. Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2010 cited by 861

  5. The First International Consensus on Mucous Membrane Pemphigoid

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Archives of Dermatology 2002 cited by 784

  6. Mycophenolate Mofetil for Ocular Inflammation

    Authors: , , , , , , , , , , , - American Journal of Ophthalmology 2009 cited by 252

  7. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review

    Authors: , , , , , , , , , , , , - Seminars in Arthritis and Rheumatism 2019 cited by 148

  8. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

    Authors: , , , , , , , , , , , - American Journal of Ophthalmology 2000 cited by 993

  9. Efficacy and Safety of Intravenous Secukinumab in Noninfectious Uveitis Requiring Steroid-Sparing Immunosuppressive Therapy

    Authors: , , , , , - Ophthalmology 2015 cited by 167

  10. Azathioprine for Ocular Inflammatory Diseases

    Authors: , , , , , , , , , , , - American Journal of Ophthalmology 2009 cited by 252

  11. Comparison of mechanical properties of keratoconus and normal corneas

    Authors: , , - Experimental Eye Research 1982 cited by 207

  12. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management

    Authors: , , , , , , - Survey of Ophthalmology 2015 cited by 196

  13. Methods for Identifying Long-Term Adverse Effects of Treatment in Patients with Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

    Authors: , , , , , , , , , , , , , , - Ophthalmic Epidemiology 2008 cited by 126

  14. Lirentelimab for severe and chronic forms of allergic conjunctivitis

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2022 cited by 47

  15. Cyclosporine for Ocular Inflammatory Diseases

    Authors: , , , , , , , , , , , - Ophthalmology 2010 cited by 262

  16. Risk of Choroidal Neovascularization among the Uveitides

    Authors: , , , , , , , , , , , - American Journal of Ophthalmology 2013 cited by 95

  17. Visual Acuity Outcome over Time in Non-Infectious Uveitis

    Authors: , , , , , , , , , , , , , , , , , , , - Ocular Immunology and Inflammation 2019 cited by 29

  18. Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study

    Authors: , , , , , , , , , , - Ophthalmology 2012 cited by 182

  19. Glaucoma and Uveitis

    Authors: , , , - Survey of Ophthalmology 2012 cited by 176

  20. The Challenge of Pediatric Uveitis: Tertiary Referral Center Experience in the United States

    Authors: , , , , , , - Ocular Immunology and Inflammation 2018 cited by 99

  21. Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment

    Authors: , , , , - Ophthalmology 2018 cited by 99

  22. Analysis of Pediatric Uveitis Cases at a Tertiary Referral Center

    Authors: , , , - Ophthalmology 2005 cited by 263

  23. Severity of Scleritis and Episcleritis

    Authors: , , - Ophthalmology 1994 cited by 213

  24. Ocular Rosacea

    Authors: , , , - Ophthalmology 1997 cited by 175